Risk Factors for Inpatient Hypoglycemia during Subcutaneous Insulin Therapy in Non-Critically Ill Patients with Type 2 Diabetes-Reference-Cited by-同舟云学术

Risk Factors for Inpatient Hypoglycemia during Subcutaneous Insulin Therapy in Non-Critically Ill Patients with Type 2 Diabetes

Published:2012-09 Issue:5 Volume:6 Page:1022-1029
ISSN:1932-2968
Container-title:Journal of Diabetes Science and Technology
language:en
Short-container-title:J Diabetes Sci Technol

Author:

Farrokhi Farnoosh¹,Klindukhova Olena¹,Chandra Prakash¹,Peng Limin²,Smiley Dawn¹,Newton Christopher¹,Pasquel Francisco¹,Fereira Maria E.¹,Umpierrez Guillermo¹

Affiliation:

1. Department of Medicine, Emory University, Atlanta, Georgia

2. School of Public Health, Emory University, Atlanta, Georgia

Publisher

SAGE Publications

Subject

Biomedical Engineering,Bioengineering,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/193229681200600505

Reference36 articles.

1. Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis*

2. Management of Hyperglycemia in the Hospital Setting

3. Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes

4. Association Between Hyperglycemia and Increased Hospital Mortality in a Heterogeneous Population of Critically Ill Patients

5. Intensive Insulin Therapy in Critically Ill Patients

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In‐Hospital Treatment and Surgery in People with Diabetes;Textbook of Diabetes;2024-01-12

2. Hypoglycemia in hospitalized patients: A sleeping monster;Muller Journal of Medical Sciences and Research;2024-01

3. Optimizing Ramadan fasting: A randomised controlled trial for people with type 2 diabetes during Ramadan applying the principles of the ADA/EASD consensus;Diabetes/Metabolism Research and Reviews;2023-01-11

4. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update;Endocrine Practice;2022-10

5. GLP‐1 receptor agonist use during hospitalisation: Better glycaemic control compared to premixed insulin;Diabetes/Metabolism Research and Reviews;2022-09-06